Impact of COVID-19 and Structural Racism on Maternal Mental Health and the Bronx MomBa Cohort

COVID-19 和结构性种族主义对孕产妇心理健康和布朗克斯 MomBa 群体的影响

基本信息

  • 批准号:
    10393077
  • 负责人:
  • 金额:
    $ 33.52万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-10-01 至 2022-02-28
  • 项目状态:
    已结题

项目摘要

Project Summary Epidemiological studies of multiple cohorts suggest an increased risk for obesity, cardiovascular disease- related death and type 2 diabetes in low birth weight infants. However, the molecular mechanisms underlying developmental programming of childhood obesity remain poorly understood. Alterations in DNA methylation during fetal life have been proposed to be one of the mechanisms that regulate this phenotype. Although association studies, using surrogate cells from cord or peripheral blood, demonstrate a relationship between changes in DNA methylation of loci and infant/child growth parameters, major knowledge gaps exist. Here, we address major questions about early childhood obesity programming by studying purified subpopulations of CD3+ T-cells from intrauterine growth restricted (IUGR) newborns who have an increased risk for obesity and other metabolic disorders in adult life. We elected to study CD3+ T-cells because of their crucial role in the regulation of adipose tissue inflammation and insulin sensitivity, factors which underlie obesity pathogenesis. We hypothesize that the adverse developmental milieu associated with IUGR will be strongly correlated with (1) altered DNA methylation profiles, and (2) functional changes in CD3+ T-cell subpopulations (e.g., CD4+, CD8+, regulatory T-cells ( Tregs)) that persist in peripheral blood T-cells until at least 24-months of age. Furthermore, the enduring epigenetic dysregulation of CD3+ T-cells and their inflammatory signaling processes will be tightly associated with increased adiposity in childhood. We propose three specific aims to address our hypothesis. In Aim 1, we will characterize the effect of IUGR on DNA methylation profiles in purified CD3+ T-cells obtained from cord blood in a prospective cohort of 300 healthy term infants at birth. The persistence of these changes in differentially methylated loci (DML) will be assessed in peripheral blood CD3+ T-cells at 24-months of age. In Aim 2, we will characterize the effect of IUGR-associated DNA methylation on CD3+ T-cell function and gene expression using purified CD4+, CD8+, and Treg cells. In Aim 3, we will determine whether DNA methylation and functional profiles of CD3+ T-cell subpopulations are associated with growth velocity and development of adiposity in the first 24-months of life. Our ultimate goal is to identify epigenetic mechanisms underlying IUGR-mediated childhood obesity in a prospectively enrolled, longitudinally followed cohort of healthy term IUGR infants compared to appropriate for gestational age (AGA) newborns. Furthermore, we will characterize functional changes associated with the newly discovered DML in CD3+ T-cells, a mechanistically relevant cell type in the pathogenesis of obesity.
项目摘要 多个队列的流行病学研究表明,肥胖、心血管疾病的风险增加, 低出生体重儿的相关死亡和2型糖尿病。然而,潜在的分子机制 儿童肥胖的发育程序仍然知之甚少。DNA甲基化的改变 在胎儿生命期间,已被认为是调节这种表型的机制之一。虽然 使用脐带血或外周血的替代细胞进行的相关性研究表明, 基因座DNA甲基化和婴儿/儿童生长参数的变化,存在重大的知识差距。这里我们 通过研究纯化的亚群来解决有关早期儿童肥胖规划的主要问题, 肥胖风险增加的宫内生长受限(IUGR)新生儿的CD 3 + T细胞, 其他代谢紊乱。我们选择研究CD 3 + T细胞,因为它们在免疫系统中发挥着关键作用。 调节脂肪组织炎症和胰岛素敏感性,这些因素是肥胖发病机制的基础。 我们推测,与IUGR相关的不良发育环境与IUGR的发生密切相关。 具有(1)改变的DNA甲基化谱,和(2)CD 3 + T细胞亚群的功能变化(例如, CD 4+、CD 8+、调节性T细胞(TCRs))持续存在于外周血T细胞中,直至至少24个月, 年龄此外,CD 3 + T细胞及其炎症信号的持久表观遗传失调 这些过程将与儿童时期肥胖症的增加密切相关。我们提出三个具体目标 来验证我们的假设 在目的1中,我们将描述IUGR对获得的纯化的CD 3 + T细胞中DNA甲基化谱的影响。 来自300名出生时健康足月婴儿的前瞻性队列的脐带血。这些变化的持续性 将在24月龄时的外周血CD 3 + T细胞中评估差异甲基化基因座(DML)。 在目标2中,我们将描述IUGR相关DNA甲基化对CD 3 + T细胞功能的影响, 使用纯化的CD 4+、CD 8+和Treg细胞进行基因表达。 在目标3中,我们将确定CD 3 + T细胞亚群的DNA甲基化和功能谱是否与T细胞亚群的DNA甲基化和功能谱相关。 与出生后24个月内的生长速度和肥胖症的发展有关。 我们的最终目标是确定IUGR介导的儿童肥胖的表观遗传机制, 前瞻性入组,纵向随访健康足月IUGR婴儿队列, 胎龄(阿加)新生儿。此外,我们还将描述与此相关的功能变化。 在CD 3 + T细胞中新发现的DML,这是肥胖发病机制中的一种机制相关细胞类型。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MAUREEN J CHARRON其他文献

MAUREEN J CHARRON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MAUREEN J CHARRON', 18)}}的其他基金

Molecular Basis of Early Childhood Obesity Programming by Intrauterine Growth Restriction
通过宫内生长受限进行儿童早期肥胖规划的分子基础
  • 批准号:
    10116433
  • 财政年份:
    2018
  • 资助金额:
    $ 33.52万
  • 项目类别:
Molecular Basis of Early Childhood Obesity Programming by Intrauterine Growth Restriction
通过宫内生长受限进行儿童早期肥胖规划的分子基础
  • 批准号:
    10359117
  • 财政年份:
    2018
  • 资助金额:
    $ 33.52万
  • 项目类别:
GLUT8 Overexpression in Cardioprotection
GLUT8 过度表达对心脏的保护作用
  • 批准号:
    7826818
  • 财政年份:
    2009
  • 资助金额:
    $ 33.52万
  • 项目类别:
Molecular Basis of Insulin Resistance
胰岛素抵抗的分子基础
  • 批准号:
    7991947
  • 财政年份:
    2009
  • 资助金额:
    $ 33.52万
  • 项目类别:
GLUT8 Overexpression in Cardioprotection
GLUT8 过度表达对心脏的保护作用
  • 批准号:
    7679886
  • 财政年份:
    2009
  • 资助金额:
    $ 33.52万
  • 项目类别:
Molecular Basis of Insulin Resistance
胰岛素抵抗的分子基础
  • 批准号:
    7463147
  • 财政年份:
    2008
  • 资助金额:
    $ 33.52万
  • 项目类别:
Molecular Basis of Insulin Resistance
胰岛素抵抗的分子基础
  • 批准号:
    7587431
  • 财政年份:
    2008
  • 资助金额:
    $ 33.52万
  • 项目类别:
Altered Glucose and Lipid Metabolism in Obesity and CVD
肥胖和心血管疾病中葡萄糖和脂质代谢的改变
  • 批准号:
    6944754
  • 财政年份:
    2003
  • 资助金额:
    $ 33.52万
  • 项目类别:
Altered Glucose and Lipid Metabolism in Obesity and CVD
肥胖和心血管疾病中葡萄糖和脂质代谢的改变
  • 批准号:
    7263925
  • 财政年份:
    2003
  • 资助金额:
    $ 33.52万
  • 项目类别:
Altered Glucose and Lipid Metabolism in Obesity and CVD
肥胖和心血管疾病中葡萄糖和脂质代谢的改变
  • 批准号:
    6602637
  • 财政年份:
    2003
  • 资助金额:
    $ 33.52万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 33.52万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.52万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 33.52万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.52万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 33.52万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 33.52万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.52万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 33.52万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 33.52万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.52万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了